Unknown

Dataset Information

0

Preclinical evaluation of [18 F]MA3: a CB2 receptor agonist radiotracer for PET.


ABSTRACT: BACKGROUND AND PURPOSE:Non-invasive in vivo imaging of cannabinoid CB2 receptors using PET is pursued to study neuroinflammation. The purpose of this study is to evaluate the in vivo binding specificity of [18 F]MA3, a CB2 receptor agonist, in a rat model with local overexpression of human (h) CB2 receptors. METHODS:[18 F]MA3 was produced with good radiochemical yield and radiochemical purity. The radiotracer was evaluated in rats with local overexpression of hCB2 receptors and in a healthy non-human primate using PET. KEY RESULTS:Ex vivo autoradiography demonstrated CB2 -specific binding of [18 F]MA3 in rat hCB2 receptor vector injected striatum. In a PET study, increased tracer binding in the hCB2 receptor vector-injected striatum compared to the contralateral control vector-injected striatum was observed. Binding in hCB2 receptor vector-injected striatum was blocked with a structurally non-related CB2 receptor inverse agonist, and a displacement study confirmed the reversibility of tracer binding. This study identified the utility of mutated inactive vector model for evaluation of CB2 receptor agonist PET tracers. [18 F]MA3 PET scans in the non-human primate showed good uptake and fast washout from brain, but no CB2 receptor-specific binding was observed. CONCLUSION AND IMPLICATIONS:Evaluation of [18 F]MA3 in a rat model with local overexpression of hCB2 receptors showed CB2 receptor-specific and reversible tracer binding. [18 F]MA3 showed good brain uptake and subsequent washout in a healthy non-human primate, but no specific binding was observed. Further clinical evaluation of [18 F]MA3 in patients with neuroinflammation is warranted. LINKED ARTICLES:This article is part of a themed section on 8th European Workshop on Cannabinoid Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.10/issuetoc.

SUBMITTER: Attili B 

PROVIDER: S-EPMC6487560 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Preclinical evaluation of [<sup>18</sup> F]MA3: a CB<sub>2</sub> receptor agonist radiotracer for PET.

Attili Bala B   Celen Sofie S   Ahamed Muneer M   Koole Michel M   Haute Chris Van Den CVD   Vanduffel Wim W   Bormans Guy G  

British journal of pharmacology 20190130 10


<h4>Background and purpose</h4>Non-invasive in vivo imaging of cannabinoid CB<sub>2</sub> receptors using PET is pursued to study neuroinflammation. The purpose of this study is to evaluate the in vivo binding specificity of [<sup>18</sup> F]MA3, a CB<sub>2</sub> receptor agonist, in a rat model with local overexpression of human (h) CB<sub>2</sub> receptors.<h4>Methods</h4>[<sup>18</sup> F]MA3 was produced with good radiochemical yield and radiochemical purity. The radiotracer was evaluated in  ...[more]

Similar Datasets

| S-EPMC7865263 | biostudies-literature
| S-EPMC5334185 | biostudies-literature
| S-EPMC11231114 | biostudies-literature
| S-EPMC7017916 | biostudies-literature
| S-EPMC5074934 | biostudies-literature
| S-EPMC6932936 | biostudies-literature
| S-EPMC10833650 | biostudies-literature
| S-EPMC8263428 | biostudies-literature
| S-EPMC9305971 | biostudies-literature